S-1 · primary offering
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
NNNN$3.66+4.13%
Anbio Biotechnology
Sector: In Vitro & In Vivo Diagnostic SubstancesIndustry: Medical - Instruments & SuppliesCountry: DEExchange: Nasdaq
Mkt Cap:$525.92M
Float & O/S:
Inst Own:
DilutionScan read 16 of Anbio Biotechnology's SEC filings and found 1 shelf registration, 1 S-1 registration and 1 completed offering on file for NNNN. The latest dilution event on file is a registration statement on Jul 9, 2026. Analysis updated Nov 2, 2026.
Signal8 Summary
Raise routes on file: effective shelf · latest dilution event 117 days ago
Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need
AI dilution summary
The dominant contractual driver and its mechanism, then each further driver ranked.
Latest dilution event
Jul 9, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Share count and cash history
Shares outstanding, potential dilution and cash over time
Completed
F-3ASR shelf registration
Issued 2026
Total capacity
Remaining
- Filed
- Effective
- Expires
- Baby shelf
Public offering
Issued 2025
Gross proceeds
Price per share
- Shares issued
- Warrant coverage
- Placement agent
Know who's about to sell into your NNNN trade
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
